BidaskClub Downgrades K2M Group (KTWO) to Hold

K2M Group (NASDAQ:KTWO) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued on Thursday.

Several other equities research analysts have also issued reports on the company. Zacks Investment Research raised K2M Group from a “sell” rating to a “hold” rating in a research note on Thursday, January 25th. Barclays reaffirmed a “buy” rating and set a $25.00 price target on shares of K2M Group in a research note on Tuesday, January 9th. Needham & Company LLC lifted their price target on K2M Group from $20.00 to $23.00 and gave the stock a “buy” rating in a research note on Tuesday, January 9th. Wells Fargo & Co lowered K2M Group from an “outperform” rating to a “market perform” rating and set a $23.00 price target for the company. in a research note on Monday, December 4th. Finally, Oppenheimer reaffirmed a “buy” rating and set a $24.00 price target on shares of K2M Group in a research note on Friday, November 10th. One research analyst has rated the stock with a sell rating, three have given a hold rating and nine have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $24.50.

K2M Group (NASDAQ:KTWO) traded up $0.09 during trading hours on Thursday, reaching $18.53. The company had a trading volume of 259,494 shares, compared to its average volume of 272,995. The company has a market capitalization of $802.89, a price-to-earnings ratio of -19.10 and a beta of 1.47. K2M Group has a 12 month low of $16.44 and a 12 month high of $25.99. The company has a quick ratio of 1.67, a current ratio of 3.06 and a debt-to-equity ratio of 0.29.

A number of hedge funds have recently modified their holdings of KTWO. Schwab Charles Investment Management Inc. lifted its stake in shares of K2M Group by 32.1% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 174,070 shares of the medical device company’s stock valued at $4,241,000 after acquiring an additional 42,290 shares during the last quarter. Legal & General Group Plc lifted its stake in shares of K2M Group by 41.4% in the 2nd quarter. Legal & General Group Plc now owns 9,561 shares of the medical device company’s stock valued at $232,000 after acquiring an additional 2,798 shares during the last quarter. Wells Fargo & Company MN lifted its stake in shares of K2M Group by 0.9% in the 2nd quarter. Wells Fargo & Company MN now owns 63,322 shares of the medical device company’s stock valued at $1,542,000 after acquiring an additional 590 shares during the last quarter. Alliancebernstein L.P. lifted its stake in shares of K2M Group by 136.4% in the 2nd quarter. Alliancebernstein L.P. now owns 83,190 shares of the medical device company’s stock valued at $2,027,000 after acquiring an additional 48,000 shares during the last quarter. Finally, Teachers Advisors LLC lifted its stake in shares of K2M Group by 67.0% in the 2nd quarter. Teachers Advisors LLC now owns 73,167 shares of the medical device company’s stock valued at $1,782,000 after acquiring an additional 29,344 shares during the last quarter. 98.84% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “BidaskClub Downgrades K2M Group (KTWO) to Hold” was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at https://www.americanbankingnews.com/2018/02/11/bidaskclub-downgrades-k2m-group-ktwo-to-hold.html.

About K2M Group

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Analyst Recommendations for K2M Group (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply